MEDICAL TECHNOLOGY REGULATION. Understanding Where We Have Been and Where We Are Going with Harmonization

Similar documents
Gary Condran Associate Director Bureau of Pharmaceutical Sciences, Therapeutic Product Directorate, HPFB, Health Canada

Current Status and Challenges of Bilateral/Multilateral Meetings

Mapping Your Success 2013 BSI Healthcare Road Show

UDI/GMDN Forum. 08:30-12:00, August 28

Global Harmonization Task Force

UDI/GMDN Forum. 08:30-12:00,September12

EU, USA and Japan (II) Reports from Regulators on Exchange Assignments

IGDRP Mission, Scope, How it works

International Regulatory Harmonization and Medical Technology Innovation. Some personal thoughts

Final Document. Title: The GHTF Regulatory Model. Authoring Group: Ad Hoc GHTF SC Regulatory Model Working Group

Medical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade

GMDN An Introduction. Mark Wasmuth CEO, GMDN Agency

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

Software as a Medical Device (SaMD)

Swissmedic, Swiss Agency for Therapeutic Products

Update on Progress Implementing the LSIF Anti- Counterfeit Medicines Action Plan

TABLE OF CONTENTS DUPONT TYVEK MEDICAL PACKAGING TRANSITION PROJECT (MPTP) EXECUTIVE SUMMARY JUNE 2016 THE FINAL PHASE EXECUTIVE SUMMARY 2

January 8, Licensing Requirements for Implantable Medical Devices Manufactured by 3D Printing; Draft Guidance. Dear Sir or Madame:

Study overview. The Global Biomedical Industry: Preserving U.S. Leadership

ICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective

Breakfast briefing: Ross DeVol Chief Research Officer Milken Institute September 22, 2011 The Phoenix Park Hotel Washington, DC

FINAL DOCUMENT. Title: Medical Devices Post Market Surveillance: Content of Field Safety Notices. Endorsed by: The Global Harmonization Task Force

LSIF Convenor s Summary Report to CTI

2013/LSIF/WKSP1/002 Summary of Life Sciences Innovation Forum Activities to Combat Counterfeit / Falsified Medicines

Medical Device and IVD Regulations in Asia-Pacific

Overview of Health Technology Assessment (HTA) from Asia Pacific Perspective

ASEAN Regulatory Harmonisation and Approval Process

REPORT OF THE SG1 MEETING HELD ON 28/31st MARCH 2006 IN SYDNEY

Joint Statement for EU-Japan Regulatory Cooperation

PDA 71 Years of Connecting People, Science and Regulation

EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS

ICH Q-IWG Integrated Training Programme

Second APEC Ministers' Conference on Regional Science & Technology Cooperation (Seoul, Korea, Nov 13-14, 1996) JOINT COMMUNIQUÉ

A FRAMEWORK FOR RISK CATEGORISATION AND CORRESPONDING CONTROLS FOR SaMD

EUROPEAN COMMISSION. Dynamic spectrum & Mobile Multimedia Services. EU policy dimension. Philippe J. Lefebvre

CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D.

Structuring Global International Cooperation in Space Exploration

WHO Regulatory Systems Strengthening Program

GROUP OF SENIOR OFFICIALS ON GLOBAL RESEARCH INFRASTRUCTURES

How to take advantage of China knowledge base?

Policy Partnership on Science, Technology and Innovation Strategic Plan ( ) (Endorsed)

SCIENCE + BEAUTY. Technical Expertise for the Beauty Industry. 6 pages total

ERAC-SFIC 1353/15 AFG/nj 1 DG G 3 C

Forum Agenda. 18:00 19:30 Welcome Dinner. 08:30-09:00 Opening of the Forum, Welcome Speeches

ENCePP Work Plan

US/GLOBAL BIOCIDES (ANTIMICROBIALS) REGULATION CONFERENCE

Annual report of the Good Manufacturing and Distribution Practice Inspectors Working Group 2017

Regulatory cooperation in APEC member economies. Evgeny Petrosyan

2014/SOM2/049 Agenda Item: 2.1. CTI Chair s Report. Purpose: Consideration Submitted by: CTI Chair

COUNCIL OF THE EUROPEAN UNION. Brussels, 9 December 2008 (16.12) (OR. fr) 16767/08 RECH 410 COMPET 550

IPEG Convenor Report to CTI

Into Moving Forward to Automated Driving. In this issue: ITS World Congress in Montreal. CARTRE and ERTRAC Joint Workshop

RCUK international engagement with Japan

The ETV pilot programme: State of play, standardisation issues

APIs global business developments

Accelerating Growth and Cost Reduction in the PV Industry

COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT. pursuant to Article 294(6) of the Treaty on the Functioning of the European Union

Reflection Paper on synergies between regulatory and HTA issues. DG SANTE Unit B4 Medical products: safety, quality, innovation

Progressive Licensing and the Modernization of the Canadian Regulatory Framework

LOREM IPSUM XXX MEDICAL DEVICES NEWS OCTOBER 2012 SPECIAL POINTS OF INTEREST: XXX EDITORIAL

March 27, The Information Technology Industry Council (ITI) appreciates this opportunity

PMDA perspective on Quality by Design for pharmaceutical products

The Medical Device Regulation: Transitioning between old and new

This document is a preview generated by EVS

EUROPEAN COMMISSION Directorate-General for Communications Networks, Content and Technology CONCEPT NOTE

Enhancing and focusing EU international cooperation in research and innovation: A strategic approach. Policy Research and Innovation

Council of the European Union Brussels, 10 November 2016 (OR. en)

COCIR SUSTAINABLE COMPETENCE IN ADVANCING HEALTHCARE

APEC Internet and Digital Economy Roadmap

EU regulatory system for robots

Preparing for the new Regulations for healthcare providers

A Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei

JPO s recent developments

US/GLOBAL BIOCIDES (ANTIMICROBIALS) REGULATION CONFERENCE

(Fig.) JPMA Industry Vision 2025

Chemicals: Future Trends in Production and Use. Implications for Chemicals Management

Compliance for Eucomed: The Medical Technology Industry s s Perspective

International Research Collaboration. - Why do it?

NCRIS Capability 5.7: Population Health and Clinical Data Linkage

A stronger system to protect the health and safety of Canadians. Exploring the Future of the Food Regulatory Framework Under the Food and Drugs Act

FDA s Evolving Approach to Pharmaceutical Quality

The New Delhi Communiqué

QbD Application in Japan: PMDA Perspective

Firm Foundation, Forward Focus

Official Journal of the European Union L 117. Legislation. Legislative acts. Volume May English edition. Contents REGULATIONS

PROPOSED DOCUMENT. Global Harmonization Task Force. Title: Medical Devices: Post Market Surveillance: Content of Field Safety Notices

International initiatives in data sharing: OECD, CODATA and GICSI. Yukiko Fukasaku Innovmond Padova 21 September 2007

Buenos Aires Action Plan

3 rd meeting of the Board of Funders Brussels, 30 June State of Play. Gustav Kalbe. Head of Unit, DG Connect European Commission

The Fourth Asia Partnership Conference of Pharmaceutical Associations

Research Infrastructures and Innovation

Building Quality into Medical Device Documentation and Impact of New Device Regulation (Context: Inhaled Drug Devices) v4

RADIO SPECTRUM COMMITTEE

FDA Centers of Excellence in Regulatory and Information Sciences

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data

The Space Frequency Coordination Group (SFCG)

The meeting was chaired by Mr. Sándor ERDŐ, representative of the Hungarian Presidency of the EU.

The Asia S&T Strategic Cooperation Promotion Program

Annual Meeting ISPE Japan Affiliate. Emerging Technology. - Age of Digital and Disruptive Innovation. Dates: 24th & 25th May, 2018

John C. W. Lim, MBBS, MSc, SM, FAMS

Transcription:

GLOBAL HARMONIZATION SUMMIT WASHINGTON DC 18 September 2014 MEDICAL TECHNOLOGY REGULATION Understanding Where We Have Been and Where We Are Going with Harmonization Laurent SELLES Senior Coordinator for International relations European Commission - Consumer Directorate General Health Technology and Cosmetics

Structure 20 years of GHTF (1992-2012) Inception of IMDRF (2011-2012): The Vision Two years of IMDRF operation (2013-2014) Considerations on: - expansion - deployment - transparency - regulatory transposition

GHTF Task Force - Conceived in 1992, rotation of Chairmanship every 3 years - Purpose: international harmonization in MD regulations for safety, effectiveness, performance adequacy/quality of MDs - Publication of harmonised guidance docs on regulatory practices. - Guidance docs for adoption by Regulatory Authorities. - GHTF cooperates with Asian Harmonisation Working Party AHWP

GHTF OPERATIONAL STRUCTURE GHTF Steering Committee SG1 Premarket evaluation SG2 Post market surveillance /vigilance SG3 Quality system SG4 Auditing SG5 Clinical safety & Performance AHWG Global Model AHWG UDI AHWG Maintenance Mode AHWG Process Improvements AHWG GMDN AHWG IAF (International Accreditation Forum)

Adoption of GHTF guidelines comparison between jurisdictions 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% AUS CND EU JPN USA not adopted pending adoption adopted in part adopted in full

ACHIEVEMENTS OF GHTF - A Global Regulatory Model - 38 Guidance documents - A world-wide reference - Aspirational vs Implementable - An effective forum for collaboration But Image of old economies, not global enough! Risk of confusion of roles (Industry Regulators)

Rationale After 20 years of GHTF Time for change! Expansion from the 5 original members Separating Industry from Regulators Outsourcing deployment to other fora (AHWP, APEC, WHO )

An aspiration to convergence AHWP IMDRF OBS. Deployment fora

IMDRF Composition International Medical Device Regulators' Forum Australia, Therapeutic Goods Administration Brazil, National Health Surveillance Agency (ANVISA) Canada, Health Canada China, China Food and Drug Administration Europe, European Commission DG Japan, Ministry of Health, Labour and Welfare and the Pharmaceuticals and Medical Devices Agency Russia, Russian Minstry of Health United States of America, US Food and Drug Administration + Observers (WHO), Affiliates (AHWP, APEC)

IMDRF Annual rotation chairmanship 2012 Australia - 1st meeting in Singapore 28 Feb- 1 March - 2nd meeting in Sydney: 25-27 September 2013 Europe - 3rd meeting in Nice/Sophia Antipolis 19-21 March - 4th meeting in Brussels 12-14 November 2014 USA - 5th meeting in San Francisco 25-27 March - 6th meeting in Washington DC 16-18 September 2015 Japan - 7th meeting in Tokyo 24-26 March - 8th meeting in Kyoto 15-17 September

IMDRF Structure 11

IMDRF Work Items (2012-2013) - Review of the NCAR system - Unique Device Identification - Medical Device Single Audit Program - Lists of Recognized Standards - Regulated Product Submission - Software as a Medical Device

IMDRF Work Item: UDI Roadmap for implementation 2012-2013 UDI Work Group US-FDA CHINA CFDA EU DG SANCO JAPAN PMDA ADVAMED HEALTH CANADA EUCOMED /EDMA DITTA JFMDA/JIRA AHWP ANVISA With some invited observers.

IMDRF UDI Guidance The IMDRF UDI Guidance was adopted as a final document (IMDRF/WG/N7:2013) by the Management Committee on 15 November 2013. IMDRF/WG/N7FINAL:2013 Final Document Title: Authoring Group: UDI Guidance Unique Device Identification (UDI) of Medical Devices IMDRF UDI Working Group Date: 9 December 2013 Despina Spanou, IMDRF Chair This document was produced by the International Medical Device Regulators Forum. There are no restrictions on the reproduction or use of this document; however, incorporation of this document, in part or in whole, into another document, or its translation into

Gradual Convergence Regulatory Harmonization Harmonization means Regulatory requirements are consistent between jurisdictions Harmonization does not mean a single regulatory system across jurisdictions Convergence is the path

IMDRF VISION Conceived as a forum to discuss future directions in medical device regulatory harmonization. The Forum builds on the work of GHTF with the aim of accelerating international medical device regulatory harmonization and convergence. Oversight by a Management Committee comprised of a voluntary group of medical device regulators from around the world and the World Health Organization.

Clues: Do you recognize this gentleman? - XV Century - Great Scientist - Revolutionary view Mikolaj Kopernik (1473-1543)

The World does not rotate around our planet!

THE SHARED VISION Jurisdiction International Trade Nat'l 'Regulation' Global Guidance Two sides of the same medal INTERNATIONAL REGULATORY CONVERGENCE!

A Chinese Saying

Thank You for your attention! Visit: WWW.IMDRF.ORG http://ec.europa.eu/health/medical-devices/index_en.htm laurent.selles@ec.europa.eu